Contact Us

Yes. ZIP6 rescue experiments require attention to ZIP10 heterodimer biology: • Construct design: use a codon-modified SLC39A6 sequence with a small C-terminal tag (FLAG, HA). ZIP6 has 8 transmembrane domains — N-terminal tags after the signal peptide are tolerated. • ZIP10 partnership: ZIP6 and ZIP10 form heterodimers; rescue interpretation should consider ZIP10 expression in HEK293. • Transport-deficient rescue: histidine-rich loop mutations or transmembrane zinc-binding residue mutations enable structure-function studies. • Functional readout: rescue should restore zinc uptake activity (FluoZin-3 imaging) and downstream EMT-related phenotypes where relevant. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

Primary applications: • Cellular zinc uptake: zinc-sensitive fluorescent probes (FluoZin-3, ZinPyr-1) or ICP-MS to quantify ZIP6-dependent zinc influx. • EMT phenotype analysis: epithelial/mesenchymal marker expression, migration assays given ZIP6's reported EMT-promoting function. • Breast cancer biology: studies of ZIP6 estrogen regulation and tumor-promoting activity in cancer contexts. • Anti-LIV-1 ADC specificity: critical genetic control for ladiratuzumab vedotin and related ZIP6/LIV-1-targeting ADCs in development. EDITGENE recommends this model for researchers investigating zinc transport biology, breast cancer EMT mechanisms, and ZIP6-targeted therapeutics.

The choice depends on whether you are studying SLC39A6 (ZIP6/LIV-1)'s role in zinc uptake or its emerging functions in epithelial-mesenchymal transition (EMT) and cancer biology. The Knockout line is appropriate for asking whether ZIP6 is required for cellular zinc influx — particularly relevant in breast cancer contexts where ZIP6 is estrogen-regulated and associated with tumor progression. Overexpression is useful for studying ZIP6 in EMT and cancer phenotypes. For ZIP6 research, the EDITGENE Knockout in HEK293 is a mechanistic platform for zinc transport biology and EMT mechanism studies. ZIP family compensation should be assessed (ZIP10 is the closest paralog and forms heterodimers with ZIP6). Rescue with wild-type or transport-deficient ZIP6 enables structure-function studies. ZIP6 is also a target for ADC development (ladiratuzumab vedotin) — the knockout serves as a specificity control.

The choice depends on whether you are studying PKM (pyruvate kinase muscle isoform)'s role in glycolysis or its functions as the principal Warburg-effect-associated PKM2 isoform in cancer. The Knockout line is the standard tool for asking whether PKM is required for cellular pyruvate generation — PKM produces two splice isoforms, PKM1 (constitutively active tetramer) and PKM2 (allosterically regulated, dimer-tetramer dynamic), with PKM2 predominating in cancer cells and supporting metabolic flexibility through reduced enzymatic activity. Overexpression is useful for studying isoform-specific PKM functions or for testing PKM2 activators. Important consideration: PKM knockout eliminates both PKM1 and PKM2 isoforms — PKLR (liver-erythrocyte PK) provides limited compensation in non-hepatocyte contexts. For cancer metabolism research, the EDITGENE PKM Knockout in A-549 is highly relevant — A-549 is an NSCLC model expressing predominantly PKM2 isoform, and PKM2 is a validated cancer metabolic target. Rescue with isoform-specific cDNAs (PKM1 versus PKM2) enables comprehensive isoform-function studies. The knockout is a critical specificity control for PKM2 activators (TEPP-46, DASA-58) and PKM2-selective inhibitors in cancer drug development.

Yes, and rescue experiments are uniquely valuable for isoform-specific studies: • Construct design: use codon-modified PKM1 or PKM2 isoform-specific cDNAs (differ in exon 9 versus exon 10) with small C-terminal tags (FLAG, HA). Each isoform has the same catalytic architecture but different regulatory properties. • Isoform-specific rescue: separate rescue with PKM1 (constitutively active tetramer) or PKM2 (allosterically regulated) enables comprehensive isoform-function studies. • Allosteric mutant rescue: PKM2 K433E mutation disrupts FBP allosteric activation, useful for studying PKM2 regulation. • Functional readout: rescue should restore pyruvate kinase activity and glycolytic flux; isoform-specific rescue reveals distinct metabolic and proliferation phenotypes. A-549 transduces efficiently with lentivirus and supports systematic isoform-specific rescue experiments.

Primary applications: • PKM1 vs PKM2 isoform-specific rescue: separate rescue with PKM1 or PKM2 cDNAs enables comprehensive isoform-function studies in cancer metabolism context. • Pyruvate kinase activity: cellular pyruvate kinase activity (lactate generation, ¹³C-glucose tracing) characterization. • Warburg effect studies: glycolytic flux analysis (Seahorse ECAR) and metabolite levels under glucose-replete and -depleted conditions. • PKM2 activator pharmacology: critical genetic control for TEPP-46, DASA-58, and other PKM2 tetramerization activators in cancer drug development. EDITGENE recommends this model for researchers investigating cancer metabolism, Warburg effect mechanisms, and PKM2-targeted therapeutic development.

Yes. Nsun2 rescue experiments are well-established for RNA modification research: • Construct design: use a codon-modified Nsun2 sequence with a small C-terminal tag (FLAG, HA). Nsun2 has N-terminal SAM-binding methyltransferase domain and C-terminal regulatory region — preserve both. • Catalytically-dead rescue: C271A/C321A double mutation in the catalytic cysteines abolishes methyltransferase activity and is the standard specificity control. • Functional readout: rescue should restore tRNA and mRNA m5C levels measured by bisulfite sequencing or mass spectrometry. TC1 mESCs require feeder cell co-culture or feeder-free conditions with LIF — lentiviral transduction of mESCs is supported but requires optimization; transgene silencing during differentiation should be monitored using silencing-resistant promoters. Confirm pluripotency markers (Oct4, Nanog, SSEA-1) and karyotype stability after rescue line generation.

Primary applications: • tRNA m5C analysis: bisulfite sequencing or mass spectrometry analysis of tRNA m5C levels (notably tRNA-Leu C34/C38, tRNA-Gly). • mRNA m5C analysis: m5C-RIP-seq or bisulfite-seq to characterize Nsun2-dependent mRNA m5C deposition. • Stem cell self-renewal: pluripotency marker (Oct4, Nanog) expression and self-renewal assays in mESC context. • Differentiation studies: directed differentiation of mESCs into the three germ layers to characterize m5C's role in lineage specification. EDITGENE recommends this mouse ESC-based model for researchers investigating m5C epitranscriptomics, RNA modification in pluripotency, and Nsun2-dependent stem cell biology.

The choice depends on whether you are studying Nsun2 (NOL1/NSUN2)'s role as the principal m5C tRNA methyltransferase or its emerging functions in mRNA m5C methylation and pluripotency. The Knockout line is the standard tool for asking whether Nsun2 is required for m5C deposition — Nsun2 generates 5-methylcytosine (m5C) modifications on tRNAs (notably tRNA-Leu C34 region), mRNAs, and ncRNAs, with established roles in stem cell biology and Dubowitz-like syndrome (NSUN2 mutations cause autosomal recessive intellectual disability). Overexpression is useful for studying Nsun2 in heterologous expression contexts. For RNA modification and stem cell research, the EDITGENE Nsun2 Knockout in TC1 mouse ESC is highly valuable — TC1 is a 129S6/SvEvTac-derived mouse embryonic stem cell line, providing a pluripotent stem cell background to study m5C's role in self-renewal and differentiation. Rescue with wild-type or catalytically-dead (C271A/C321A double mutation in the catalytic cysteines) Nsun2 enables structure-function studies. The mouse ESC background uniquely enables differentiation studies to characterize m5C's role in lineage specification. The model is valuable for m5C epitranscriptomics research.

Yes. NLRP3 rescue experiments are well-established for microglial neuroinflammation research: • Construct design: use a codon-modified Nlrp3 sequence with a small C-terminal tag (FLAG, HA). Mouse Nlrp3 has N-terminal PYD, NACHT, and C-terminal LRR — preserve all elements. • CAPS mutation rescue: patient-derived activating mutations (R262W, D305N, Y570C, V200M corresponding human numbering) introduced for genotype-function studies of cryopyrin-associated periodic syndromes. • Activation-deficient rescue: Walker A motif mutations in NACHT abolish NTP binding and inflammasome activation. • Functional readout: rescue should restore LPS-priming + nigericin-induced ASC speck formation, caspase-1 cleavage, IL-1β/IL-18 release, and gasdermin-D-mediated pyroptosis. BV-2-specific considerations: • BV-2 is an immortalized murine microglial cell line (v-raf/v-myc transformed C57BL/6 microglia) — the most widely used continuous microglial cell line for in vitro neuroimmunology research. • Lentiviral transduction is supported with moderate efficiency; characterize basal microglial activation state (M1/M2 markers) before phenotypic assays. • BV-2 retains key microglial markers (CD11b, Iba1, CD68) and TLR/inflammasome responses, but immortalization may alter some primary microglial features — confirm relevant phenotypes in independent assays.

The choice depends on whether you are studying NLRP3 inflammasome activation in microglia or modeling NLRP3-mediated neuroinflammation in Alzheimer's disease, Parkinson's disease, and other neurodegenerative contexts. The Knockout line is the standard tool for asking whether NLRP3 is required for microglial inflammasome assembly — NLRP3 in microglia responds to amyloid-β fibrils, α-synuclein aggregates, tau, and other DAMPs implicated in neurodegeneration. Overexpression is useful for studying CAPS-associated gain-of-function NLRP3 mutations. For neuroinflammation research, the EDITGENE Nlrp3 Knockout in BV-2 is uniquely valuable — BV-2 is the most widely used immortalized murine microglial cell line, providing a tractable system for studying microglial NLRP3 biology relevant to neurodegenerative disease. Rescue with wild-type or CAPS-associated activating mutant (e.g., R262W, D305N, Y570C) NLRP3 enables comprehensive disease genotype-function studies. The knockout is a critical specificity control for MCC950/CRID3 (and clinical candidates inzomelid, somalix) and dapansutrile (OLT1177, in clinical trials for heart failure and gout) in neurological drug development.

Primary applications: • Microglial inflammasome activation: LPS-priming followed by NLRP3 activators (nigericin, ATP, monosodium urate crystals) to characterize NLRP3-dependent IL-1β/IL-18 release. • Neurodegeneration-relevant activation: amyloid-β fibrils, α-synuclein, tau, and other CNS DAMP-induced NLRP3 activation studies in microglia. • CAPS mutation modeling: rescue with patient-derived activating mutations (R262W, D305N, Y570C, V200M) for genotype-function studies of cryopyrin-associated periodic syndromes. • NLRP3 inhibitor specificity: critical genetic control for MCC950/CRID3 (and clinical candidates inzomelid, somalix), dapansutrile (OLT1177), and emerging NLRP3 inhibitors in neurodegenerative disease drug development. EDITGENE recommends this microglial model for researchers investigating neuroinflammation, NLRP3-mediated neurodegenerative disease mechanisms, and CNS-targeted NLRP3 inhibitor development.

Transfecting suspension cells is generally more challenging. However, due to its superior performance, this product works efficiently not only in adherent cells but also in suspension cells. For example, in Jurkat cells, 48 hours post-transfection, editing efficiency can reach up to 97%, demonstrating the product’s high efficiency in suspension cell transfection and meeting demanding requirements.

The product utilizes advanced biomolecular transfection technology. Compared with the toxicity of traditional chemical transfection methods and the physical stress of electroporation, it shows significant advantages in preserving cell viability.

If gene knockout fails when using this kit, EDITGENE will not charge for the kit. Additionally, the fee you paid for the kit can be directly applied toward EDITGENE’s gene knockout service, ensuring that your gene editing experiments proceed without concerns.